Literature DB >> 26594873

Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophrenia.

Olaoluwa Okusaga1, Erica Duncan2, Patricia Langenberg3, Lena Brundin4, Dietmar Fuchs5, Maureen W Groer6, Ina Giegling7, Kelly A Stearns-Yoder8, Annette M Hartmann7, Bettina Konte7, Marion Friedl7, Lisa A Brenner9, Christopher A Lowry10, Dan Rujescu7, Teodor T Postolache11.   

Abstract

Toxoplasma gondii (T. gondii) chronic infection and elevated kynurenine (KYN) levels have been individually associated with non-fatal suicidal self-directed violence (NF-SSDV). We aimed to test the hypothesis that the association between T. gondii seropositivity and history of NF-SSDV would be stronger in schizophrenia patients with high plasma KYN levels than in those with lower KYN levels. We measured anti-T. gondii IgG antibodies and plasma KYN in 950 patients with schizophrenia, and used logistic regression to evaluate the relationship between NF-SSDV and KYN in patients who were either seropositive or seronegative for T. gondii. For those with KYN levels in the upper 25th percentile, the unadjusted odds ratio for the association between NF-SSDV history and KYN in T. gondii seropositive patients was 1.63 (95% CI 1.01 to 2.66), p = 0.048; the adjusted odds ratio was 1.95 (95% CI 1.15 to 3.30), p = 0.014. Plasma KYN was not associated with a history of NF-SSDV in T. gondii seronegative patients. The results suggest that T. gondii and KYN may have a nonlinear cumulative effect on the risk of NF-SSDV among those with schizophrenia. If confirmed by future longitudinal studies, this result is expected to have both theoretical and clinical implications for the prevention and treatment of suicidal behavior. Published by Elsevier Ltd.

Entities:  

Keywords:  Kynurenine; Non-fatal suicidal self-directed violence; Schizophrenia; Toxoplasma gondii

Mesh:

Substances:

Year:  2015        PMID: 26594873     DOI: 10.1016/j.jpsychires.2015.10.002

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  15 in total

1.  Positive association between Toxoplasma gondii IgG serointensity and current dysphoria/hopelessness scores in the Old Order Amish: a preliminary study.

Authors:  Abhishek Wadhawan; Aline Dagdag; Allyson Duffy; Melanie L Daue; Kathy A Ryan; Lisa A Brenner; John W Stiller; Toni I Pollin; Maureen W Groer; Xuemei Huang; Christopher A Lowry; Braxton D Mitchell; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-22       Impact factor: 0.581

Review 2.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

Review 3.  The known and missing links between Toxoplasma gondii and schizophrenia.

Authors:  Hany M Elsheikha; Dietrich Büsselberg; Xing-Quan Zhu
Journal:  Metab Brain Dis       Date:  2016-04-04       Impact factor: 3.584

4.  Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.

Authors:  Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache
Journal:  Pteridines       Date:  2016-10-21       Impact factor: 0.581

Review 5.  Toxoplasma gondii-A Gastrointestinal Pathogen Associated with Human Brain Diseases.

Authors:  E G Severance; J Xiao; L Jones-Brando; S Sabunciyan; Y Li; M Pletnikov; E Prandovszky; R Yolken
Journal:  Int Rev Neurobiol       Date:  2016-10-04       Impact factor: 3.230

Review 6.  Schizophrenia and Infections: The Eyes Have It.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

7.  Association of T. gondii infection with suicide: a systematic review and meta-analysis.

Authors:  Eissa Soleymani; Fariba Faizi; Rashid Heidarimoghadam; Lotfollah Davoodi; Younes Mohammadi
Journal:  BMC Public Health       Date:  2020-05-24       Impact factor: 3.295

Review 8.  Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders.

Authors:  Thomas A Pollak; Jonathan P Rogers; Robert G Nagele; Mark Peakman; James M Stone; Anthony S David; Philip McGuire
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

Review 9.  The kynurenine pathway: a finger in every pie.

Authors:  Jonathan Savitz
Journal:  Mol Psychiatry       Date:  2019-04-12       Impact factor: 15.992

10.  Polymorphisms in CRYBB2 encoding βB2-crystallin are associated with antisaccade performance and memory function.

Authors:  Ina Giegling; Annette M Hartmann; Just Genius; Bettina Konte; Stephan Maul; Andreas Straube; Thomas Eggert; Christoph Mulert; Gregor Leicht; Susanne Karch; Ulrich Hegerl; Oliver Pogarell; Sabine M Hölter; Hans-Jürgen Möller; Jochen Graw; Dan Rujescu
Journal:  Transl Psychiatry       Date:  2020-04-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.